Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen and CYP2D6 in Metastatic Breast Cancer
NCT01124695Phase 2Completed
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Jan 2011
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tamoxifen in breast cancer, sponsored by ECOG-ACRIN Cancer Research Group. Started Jan 2011; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01124695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124695.